Form 4: Fulgent Genetics' President and COO Jian Xie Reports Stock Transaction
SEC Form 4
Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On August 3, 2024, Jian Xie, the President and COO of Fulgent Genetics, had 6,719 shares of common stock withheld to cover tax obligations.
- The shares were withheld at a price of $25.06 per share.
- Following the transaction, Mr. Xie directly owns 343,479 shares of Fulgent Genetics common stock.
- Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust, for which he serves on the investment committee.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard tax withholding related to stock vesting, not indicative of positive or negative sentiment towards the company.
Industry Context
This is a routine disclosure of insider transactions, which is common for executives of publicly traded companies. It provides transparency into the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| January 27, 2010 | Date of The Hsieh Family Dynasty Trust |
| August 3, 2020 | Date of original restricted stock units grant |
| August 5, 2020 | Date Form 4 was filed for original restricted stock units grant |
| August 3, 2024 | Date of stock transaction (tax withholding) |
| August 6, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.